News Release

Wash U Medicine Cancer study professional recognized with Clinical Research Integrity Award by Alliance for Clinical Trials in Oncology

Jennifer Frederick received Clinical Research Professional Research Integrity Service Excellence Award for dedication to helping cancer patients access clinical trials

Grant and Award Announcement

Alliance for Clinical Trials in Oncology

Jennifer Frederick and Dr. Evanthia Galanis, Alliance Group Chair

image: 

Wash U Medicine oncology clinical trial organizer Jennifer Frederick has received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award (CRP RISE) from Dr. Evanthia Galanis, Group Chair for the Alliance for Clinical Trials in Oncology. This award honors clinical research professionals (CRPs) who exemplify excellence in cancer clinical trials through quality, patient advocacy, professional development, and leadership with compassion, integrity, respect, safety, and teamwork.

view more 

Credit: Alliance for Clinical Trials in Oncology

Wash U Medicine oncology clinical trial organizer Jennifer Frederick has received the 2026 Alliance Clinical Research Professionals Research Integrity Service Award (CRP RISE) from the Alliance for Clinical Trials in Oncology. This award honors clinical research professionals (CRPs) who exemplify excellence in cancer clinical trials through quality, patient advocacy, professional development, and leadership with compassion, integrity, respect, safety, and teamwork.

“Clinical research professionals are the backbone of clinical trials as they work with patients and their families daily to explain study details, ensure protocol compliance, monitor side effects, collect data, and overall ensure that trials run smoothly and safely,” said Erin E. Lynch, MS, Co-Chair of the Alliance Clinical Research Professionals Committee and Administrative Director in the Cancer Center Clinical Trials Office at Medical College of Wisconsin/Froedert Clinical Cancer Center. “Jennifer really stood out to the committee for her dedication to ensuring new clinical trials are opened quickly to allow more patients access to the latest study offerings. We are delighted to bestow this honor upon her.”

“My work has always been about ensuring participants have access to the latest clinical trial options,” said Frederick. “I am especially passionate about helping patients who may have special circumstances and need a little more help as they consider joining a study. It’s an honor to be recognized by the Alliance.”

Frederick joined Wash U in 2018 as a regulatory coordinator focused on managing cooperative group studies, such as those offered by the Alliance. In 2021, she advanced to become a supervisor of the regulatory team for cooperative group studies in medical and radiation oncology. Frederick and her team are responsible for ensuring participant accrual, safety and compliance for more than 250 cooperative group studies. Recently, Frederick’s team was recognized for their ability to activate new trials quickly, demonstrating operational agility, strong cross-functional collaboration, and a commitment to accelerating trial start-up timelines.

“Jennifer is really the best among us, always remembering to put the participant experience at the core of our work. Undergoing cancer treatment is a very stressful time for a patient and their family. That’s why one of the reasons Jenn works so hard to ensure joining a clinical trial is as smooth a process as possible for participants and their families,” said Jason Atkinson, Clinical Research Manager at Wash U and a Co-Chair of the Alliance Clinical Research Professionals Committee. “As a colleague, I am continually impressive by her capacity to achieve so much, so consistently.”   

###

The Alliance for Clinical Trials in Oncology is a national leader in advancing cancer research, uniting more than 26,000 cancer specialists at 112 main institutions and 1,400 affiliates across the U.S. and Canada. As part of the National Clinical Trials Network and a leading research base for the NCI Community Oncology Research Program, the Alliance conducts pioneering, practice-changing clinical trials that improve outcomes and reshape standards of care. Our work has led to multiple FDA approvals, influenced national guidelines, and produced hundreds of high-impact publications. More than 40,000 participants have taken part in Alliance studies, and our growing biospecimen repository now includes more than 1.5 million samples, collected over the past 30 years. Learn more at www.AllianceforClinicalTrialsinOncology.org.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.